Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

996
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
996

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An encyclopedia of human enhancer-gene regulatory interactions.

Nature·2026
Same author

Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis.

Nature communications·2026
Same author

ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.

The Journal of experimental medicine·2026
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL.

Blood·2026
Same author

Regulatory landscape of widespread stop codon readthrough in <i>Drosophila</i>.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 22, 2025

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
10:05

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

1.9K

Targeting IL-1 controls refractory pityriasis rubra pilaris.

Eloi Schmauch1,2,3, Yannik Severin4, Xianying Xing5

  • 1Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Science Advances
|July 3, 2024
PubMed
Summary

Pityriasis rubra pilaris (PRP) is driven by Interleukin-1 beta (IL-1β). Targeting IL-1β with specific antagonists rapidly improved patient skin lesions and reversed disease markers, suggesting a new classification for this rare inflammatory skin condition.

More Related Videos

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.4K
Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

11.0K

Related Experiment Videos

Last Updated: Jun 22, 2025

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
10:05

Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ

Published on: May 8, 2020

1.9K
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.4K
Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

11.0K

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disorder with unclear causes.
  • Understanding the molecular mechanisms of PRP is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the underlying molecular pathways in Pityriasis rubra pilaris (PRP).
  • To identify key mediators and potential therapeutic targets for PRP.

Main Methods:

  • Molecular pathway analysis of skin samples from PRP patients, psoriasis, atopic dermatitis, healed PRP, and healthy controls.
  • Investigated the role of Interleukin-1 beta (IL-1β) and associated signaling pathways (NF-κB, CARD14, NOD2).
  • Treated three PRP patients with IL-1β antagonists (anakinra, canakinumab) and analyzed clinical and molecular responses.

Main Results:

  • Identified IL-1β as a central mediator in PRP, driving an NF-κB-mediated IL-1β-CCL20 axis.
  • IL-1β stimulation of keratinocytes in vitro mirrored the transcriptional signature observed in PRP.
  • Treatment with IL-1β antagonists led to rapid clinical improvement (50% lesion reduction in 2-3 weeks) and reversal of molecular markers.

Conclusions:

  • IL-1β is a key therapeutic target for Pityriasis rubra pilaris (PRP).
  • Findings support redefining PRP as an autoinflammatory keratinization disorder.
  • Further clinical trials are warranted to confirm the efficacy of IL-1β antagonists in PRP treatment.